MedTrace Logo

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

NCT02015455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250401

Last updated 2022-02-14

Study results available
· View outcomes & findings →

Summary

The overall goal of the Lumbar Image Reporting with Epidemiology (LIRE) is to perform a large, pragmatic, cluster randomized controlled trial to determine the effectiveness of a simple, inexpensive and easy to deploy intervention - insertion of epidemiological benchmarks into lumbar spine imaging reports - at reducing subsequent tests and treatments. The investigator's main hypothesis is that for patients referred from primary care providers, inserting epidemiological evidence in lumbar spine imaging reports will reduce subsequent diagnostic and therapeutic interventions, including cross-sectional imaging (MR/CT), opioid prescriptions, spinal injections and surgery.

Conditions

  • Low Back Pain
  • Back Pain
  • Lumbar Pain
  • Backache

Interventions

OTHER

Epidemiologic benchmarks included in lumbar imaging reports

Epidemiologic benchmarks inserted into lumbar imaging reports

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Henry Ford Health System

    collaborator OTHER

  • Kaiser Permanente

    collaborator OTHER

  • Oregon Health and Science University

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • University of Washington

    lead OTHER

Principal Investigators

  • Jeffrey G Jarvik, MD, MPH · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2018-12-14
Completion
2018-12-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02015455 on ClinicalTrials.gov